Rituximab for the treatment of high titre inhibitors in mild haemophilia A

MeSH terms

• Antibodies, Monoclonal, Murine-Derived / therapeutic use*
• Antifibrinolytic Agents / therapeutic use
• Appendicitis / complications
• Appendicitis / surgery
• B-Lymphocytes
• Blood Loss, Surgical / prevention & control
• Child
• Deamino Arginine Vasopressin / therapeutic use
• Factor VIII / administration & dosage
• Factor VIII / genetics
• Factor VIII / immunology*
• Factor VIII / therapeutic use
• Factor VIIa / therapeutic use
• Hemophilia A / complications
• Hemophilia A / genetics
• Hemophilia A / immunology*
• Humans
• Immunosuppressive Agents / therapeutic use*
• Infusions, Intravenous
• Isoantibodies / blood*
• Isoantibodies / immunology
• Lymphocyte Count
• Male
• Mutation, Missense
• Peritonitis / etiology
• Peritonitis / surgery
• Postoperative Hemorrhage / drug therapy
• Postoperative Hemorrhage / etiology
• Recombinant Proteins / therapeutic use
• Rituximab